XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
  Depression
  Neuropsychiatry
  Personality Disorders
  Bulimia
  Anxiety
  Substance Abuse
   Alcohol
   Smoking
   Amphetamine
   Opiates
   Cannabis
   Cocaine
  Suicide
  CFS
  Psychoses
  Child Psychiatry
  Learning-Disabilities
  Psychology
  Forensic Psychiatry
  Mood Disorders
  Sleep Disorders
  Peri-Natal Psychiatry
  Psychotherapy
  Anorexia Nervosa
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Substance Abuse Channel
subscribe to Substance Abuse newsletter

Latest Research : Psychiatry : Substance Abuse

   DISCUSS   |   EMAIL   |   PRINT
Alternative to methadone in opioid dependance
Jun 28, 2005, 23:48, Reviewed by: Dr.

"We found that individuals seeking buprenorphine did differ from those seeking methadone along several important variables--age, sex, ethnicity, employment status, etc.," said Lynn Sullivan, M.D., assistant professor of internal medicine at Yale School of Medicine. " Results suggest that buprenorphine is having some success in reaching individuals who are unable or unwilling to use methadone for opioid addiction."

 
Patients who receive buprenorphine treatment for opioid addiction in an office�based setting are more likely than those receiving methadone treatment to be young men, new to drug use, and with no history of methadone treatment, Yale School of Medicine researchers report in a study published in Drug and Alcohol Dependence.
Approved for treating heroin and prescription opiate pain killer abuse in 2002, office�based buprenorphine holds the promise of bringing new patients into treatment. While heroin and prescription opiate pain killer abuse has substantially increased over the years, the availability of treatment has not increased with the demand.

Along with her colleagues, Lynn Sullivan, M.D., assistant professor of internal medicine at Yale School of Medicine, evaluated whether office�based buprenorphine treatment in a primary care clinic was associated with a different patient population receiving treatment compared to patients enrolling in methadone maintenance.

"We found that individuals seeking buprenorphine did differ from those seeking methadone along several important variables--age, sex, ethnicity, employment status, etc.," said Sullivan. " Results suggest that buprenorphine is having some success in reaching individuals who are unable or unwilling to use methadone for opioid addiction."

Demographic information and the individual's history of drug abuse were compiled from 190 patients seeking treatment for opioid addiction.

Individuals that received buprenorphine, compared to those that sought out methadone treatment, were more likely to be male, employed, have five fewer years of opioid addiction, have lower rates of injection drug use, lower rates of hepatitis C infection and have no prior history of methadone treatment.

 

- Citation: Drug and Alcohol Dependence, 79, 113�116 (July 2005).
 

 
Subscribe to Substance Abuse Newsletter
E-mail Address:

 

Other authors on the study included Marek Chawarski, Patrick G. O'Connor, Richard S. Schottenfeld and David A. Fiellin.

Related Substance Abuse News

Scientists design simple dipstick test for cocaine, other drugs
C. elegans provides model for the genetics of nicotine dependence
Research links 'ecstasy' to survival of key movement-related cells in brain
Smoking Ban Associated With Rapid Improvement In Health Of Bar Workers in Scotland
Smoking media literacy (SML) is a valuable tool in efforts to discourage teens from smoking
DNA highly-promising predictor for successful treatment of alcoholics
Hold the Hookah
Weight concerns affects women's motivations to stay smoke-free after delivery
Nicotine Withdrawal Begins Within 30 Minutes
Varenicline Appears Effective In Helping Smokers Kick The Habit


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us